The primary objective of the study : to compare the Recurrence-Free survival (RFS) between arms. RFS is defined as time from randomisation to the first recurrence (either local-regional or distant) or death of any cause.
18 < Age < 75 years old
ECOG performance status ≤1
Preoperative chemotherapy is allowed. Maximum of 4 cycles are authorized. Surgery should be realized ≤ 2 months after the last chemotherapy injection.
Histologically diagnosed thymoma at pathological examination of surgical specimen after pathological review; for note, centralized, real-time, systematic pathological review is standard through the RYTHMIC network in France
None
Parallel
Radiotherapy
Other interventionpostoperative radiotherapy after complete resection of thymoma
Surveillance after resection
Other interventionSurveillance after tumour resection
Recurrence-Free survival (RFS)
to compare the Recurrence-Free survival (RFS) between arms. RFS is defined as time from randomisation to the first recurrence (either local-regional or distant) or death of any cause.
Local-regional (pleural or pericardial) recurrence
Local-regional (pleural or pericardial) recurrence; location of recurrence /removed
Click on the lead sponsor to view all of their trials.
